
Opinion|Videos|November 25, 2025
The Burden and Unmet Needs Associated with Desmoid Tumors
Patients with desmoid tumors face significant clinical and economic burdens, impacting their quality of life and leading to ongoing treatment challenges.
Advertisement
Episodes in this series

Panelists discuss the questions below in this video.
- There any molecular biomarkers that are commonly associated with desmoid tumor?
- What is the role of biomarker testing in patients with suspected diagnosis? What makes the definitive diagnosis?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Accept Deidentified Real-World Evidence for Select Medical Device Applications
2
COVID-19 Vaccination in Pregnant Patients Reduces Hospitalization, Preterm Birth Across Variants
3
FDA Approves Fam-Trastuzumab Deruxtecan-Nxki for Metastatic HER2-Positive Breast Cancer
4
Pembrolizumab Achieved pCR in Patient With Recurrent DDLPS
5








































